Home
About
Overview
Sharing Data
ORCID
Help
History (88)
Influenza virus drug resistance: a time-sampled population genetics perspective.
Drug resistance conferred by mutations outside the active site through alterations in the dynamic and structural ensemble of HIV-1 protease.
CRISPR-Cas9-mediated saturated mutagenesis screen predicts clinical drug resistance with improved accuracy.
Direct delivery of Cas-embedded cytosine base editors as ribonucleoprotein complexes for efficient and accurate editing of clinically relevant targets.
Advancements in Targeted Therapies for Vitiligo: Prioritizing Equity in Drug Development.
See All 88 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Advancements in Targeted Therapies for Vitiligo: Prioritizing Equity in Drug Development.
Delva C, Pearson TF, Harris JE. Advancements in Targeted Therapies for Vitiligo: Prioritizing Equity in Drug Development. Cutis. 2024 Apr; 113(4):156-158.
View in:
PubMed
subject areas
Dermatologic Agents
Humans
Molecular Targeted Therapy
Vitiligo
authors with profiles
John E Harris MD, PhD